GlassScriptPhysician profile
Abraham Anthony Chamely
NPI 1407806060
$865.55
in general payments reported to CMS, 2019-2025
17 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2020: $87.11 · 2021: $23.62 · 2023: $181 · 2024: $23.65 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $164.19 | 2023-2025 | |
| Lilly USA, LLC | $162.03 | 2019-2025 | Kisunla |
| Amgen INC. | $152.90 | 2019-2021 | |
| Acorda Therapeutics, INC | $77.96 | 2019-2020 | |
| Allergan, INC. | $44.15 | 2020 | |
| Novartis Pharmaceuticals Corporation | $38.69 | 2019-2020 | |
| Argenx US, INC. | $33.12 | 2025 | Vyvgart Hytrulo |
| Janssen Biotech, INC. | $31.31 | 2025 | |
| C2n Diagnostics, LLC | $23.68 | 2025 | Precivityad2 |
| Avid Radiopharmaceuticals, INC. | $23.65 | 2024 | |
| Life Molecular Imaging LTD | $22.70 | 2023 | Neuraceq |
| Biogen, INC. | $20.81 | 2019 | |
| Ceribell, INC. | $20.00 | 2025 | Pocket Eeg Device |
| Abbvie INC. | $14.64 | 2023 | Botox |
| Emd Serono, INC. | $13.17 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $11.29 | 2021 | |
| Csl Behring | $11.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abraham Chamely listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.